An Independent Review Of Arterial Occlusive Events (Aoes) In The Ponatinib (Pon) Phase Ii Pace Trial (Nct01207440) In Patients (Pts) With Ph Plus Leukemia.
JOURNAL OF CLINICAL ONCOLOGY（2020）
摘要
7550Background: The final 5-year analysis of the PACE trial, which evaluated use of PON in pts with refractory chronic myeloid leukemia (CML) and Ph+ acute lymphoblastic leukemia, identified a 25% ...
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要